Q2 2017 Holdings
Filed 2017-08-11 | 19 holdings | $59.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $27.4M | 986,492 | 46.1% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $13.8M | 2,475,167 | 23.2% |
| Argenx(ARGX) | COM | 04016X101 | $13.6M | 647,015 | 22.9% |
| CytomX Therapeutics Inc(CTMX) | COM | 23284F105 | $4.5M | 288,915 | 7.5% |
| AveXis Inc | COM | 05366U100 | $77.0K | 1,035,657 | 0.1% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $37.9K | 1,664,300 | 0.1% |
| Edge Therapeutics Inc | COM | 279870109 | $19.8K | 1,933,582 | 0.0% |
| DBV Technologies | COM | F2927N109 | $18.9K | 373,617 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $14.4K | 769,771 | 0.0% |
| Axovant Sciences Ltd | COM | G0750W104 | $7.0K | 301,718 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $4.8K | 156,880 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $2.6K | 1,078,932 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $2.0K | 426,297 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $1.6K | 221,651 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $1.6K | 386,928 | 0.0% |
| Ocera Therapeutics | COM | 67552A108 | $1.4K | 1,217,872 | 0.0% |
| Obseva SA | COM | H5861P103 | $1.3K | 150,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $700 | 280,000 | 0.0% |
| Sierra Oncology Inc | COM | 82640U107 | $153 | 130,798 | 0.0% |